KR20140137289A - Composition comprising an extract of Alpinia officinarum Hance for preventing and treating hangover or liver disease - Google Patents

Abstract

The present invention relates to a composition containing an extract of Alpinia officinarum hance for treating and preventing hangover and liver disease. The extract is proven in an animal test to have effects of alleviating hangover and treating liver disease that substantially reduces ethanol in the blood the density of ALT/AST enzymes. Therefore, the extract can be used for the composition for treating and preventing hangover and liver disease.

Description

TECHNICAL FIELD The present invention relates to a composition for treating and preventing hangover and liver disease,

The present invention relates to a composition for the prevention and treatment of hangover and liver disease, which contains a peroral extract as an active ingredient.

[Document 1] Choi HB. 2009. Alcoholic liver disease. Korean J Gastroenterol 53: 275-282.

[Document 2] Disease Control Headquarters, 2012 Community Health Survey Report

[Literature 3] Disease Control Headquarters, Adult Drinking Status Report in Korea. 2012

[Literature 4] Lee EH, Chyun JH. 2005. Effects of beta-carotene supplementation on lipid peroxide levels and antioxidative enzyme activities in alcoholic fatty liver rats. Korean J Nutr 38: 289-296.

[Literature 5] Rouach H, Clement M, Andanelli MT, Nordmann R. 1983. Hepatic lipid peroxidation and mitochondrial susceptibility to peroxidative attack during ethanol inhalation and withdrawal. Biochim Biophys Acta 753: 439-444.

[Literature 6] Trends in hangover, beverage market, food world. Korea Food Information Service, p 6, 2009

[Literature 7] Park, Jae-Soo Lee, Jong-Seop Lee, Ki-Nam 1997. A Study on the Detoxification Effect of Cadmium Toxin Using a Pasteurization Solution. Korean Journal of Oriental Preventive Medicine 1 (1): 76-84.

[Literature 8] Kim, Donghee Kim, Sung-Hoon Kim, Sung-Hoon Kim, 1995. Effects of Combination of Anticancer Activity (Anti-Cancer Activity) and Anticancer Agent on Liver Cancer Cells of Fractional Pancreas Effect of use. Journal of Korean Oriental Medical Society 16 (2): 386-413.

[Literature 9] Lee Eunbang Kim, Jung Keun Kim, Ok-kyung, Journal of Pharmacopoeia 24 (4): 313-318.

[Literature 10] Jang, Moon-Hee, Jae-Song, Bae, Young, 2012. Effects of Porphyrae on Th2 cytokine expression in MC / 9 mast cells. Journal of Sasang Constitutional Surgery 24 (1): 54-65.

[Literature 11] Liao Hua, Song Sun Ho, and In-Hye Ham, 2010. A Comparative Study on the Anti-inflammatory Effect and Component Contents of Five Domestic Pigments. The Korean journal of herbology 25 (4): 77-84

[Literature 12] Current issue, Jong Kwan Kim, Kwon Seung Taek. 2011. The protective effect of food composition including hinoki extracts on acute alcoholism. Korean Journal of Food Science and Nutrition 40 (8): 1107-1112

[Literature 13] Park, Jeong-eun, Soju, and Oh Suk-heung. 2006. Effects of Stevia (Stevia. Rebaudian Bertoni) Extract Supplementation on Lipid Metabolism and Liver Function in Chronic Alcohol-Fed Rats. Korean journal of human ecology 9 (1): 71-80

[Literature 14] Lee Soo Jung, Kang Min Jung, Shin Jung Hye. 2009. Effects of Garlic and Herbal Extracts on Liver Function and Lipid Metabolism by Alcohol Administration. Journal of the Korean Society of Food Science and Nutrition 38 (5): 561-568

In Korea, liver disease mortality rate is very high, 23.5 per 100,000 population (37.8 males and 9.0 females), and the number of deaths in South Korea is the highest (41.1 / 100,000) and the second highest among the 50 deaths (72.4 / 100,000) , The third leading cause of death in the 30s (10 people / 100,000 people), is the leading cause of death in the Korean middle-aged population. Especially alcoholic liver disease is a disease that can occur in most of chronic overdoses.

Liver is a very important organ in charge of metabolism, detoxification, degradation, synthesis and secretion in our body. First, the liver has the function of managing the energy metabolism, and metabolizes all the nutrients absorbed from food into a substance capable of producing energy, and supplies or stores the whole body. Second, the liver has a function of synthesizing, storing and distributing fat of about 2,000 kinds of enzymes, albumin, serum proteins of bile coagulation factors, bile acid, phospholipid and cholesterol. Third, the liver has a function to excrete various metabolites through the bile duct into the duodenum, and it plays an important role in maintaining our life because of its immune function. Finally, the liver has detoxification and decomposition functions to detoxify drugs, toxic substances and alcohol. However, the hepatocyte detoxification function of this liver is liable to damage the drug, toxic and alcoholic liver disease can cause.

Alcoholic liver disease can be divided into alcoholic fatty liver disease, alcoholic hepatitis, and alcoholic cirrhosis according to the clinical symptoms. It usually occurs when 60 to 80 g of alcohol is consumed for 10 years. Alcoholic fatty liver is caused by accumulation of cholesterol and triglyceride in hepatocyte due to excessive alcohol consumption. It can be recovered soon after this week, but if it continues drinking, it develops into hepatitis. Alcoholic hepatitis has necrosis and inflammation of hepatocytes, and it has various symptoms such as fatigue, anorexia, weight loss, jaundice, fever, right upper abdominal pain, and about 40% of the patients develop alcoholic cirrhosis. Alcoholic cirrhosis is a condition in which normal liver can not be recovered. It has various symptoms such as systemic fatigue, loss of appetite, ascites, esophageal varices, hemorrhage, hepatic encephalopathy and coma, and has a worse prognosis than liver cirrhosis due to hepatitis virus. It is known that 50% of deaths from end-stage liver disease are due to alcohol.

The normal course of ethyl alcohol metabolism is the absorption of ethyl alcohol into the body is absorbed in the stomach or small intestine into the blood and then transferred to the liver. Hepatocytes have alcohol dehydrogenase (ADH), which oxidizes alcohol to acetaldehyde. The acetaldehyde is decomposed into acetic acid by acetaldehyde dehydrogenase in hepatocytes and transferred to muscle or fat tissue of the whole body And finally decompose into carbon dioxide and water. In addition, the acetaldehyde dehydrogenase enzyme has type Ⅱ which initiates oxidation even when acetaldehyde is low in concentration, and type Ⅰ which does not work if acetaldehyde is not concentrated in high concentration. However, Asian people generally have deficiency or lack of Ⅱ type acetaldehyde enzyme Therefore, the oxidation of acetaldehyde is slow, and therefore the normal metabolism is inhibited by the toxic action of acetaldehyde and / or ethyl alcohol which is not oxidized, and various hangover phenomenon is felt. In order to solve the hangover phenomenon after drinking such alcoholic beverages, there have been developed many kinds of drinks which are prepared by using a herbal medicine agent or an artificial agent alone or in combination.

Alcohol is considered to be food or medicine, and it can be seen that humans act as a lubricant, a diversion agent or a mental stimulant, which is necessary for social activities. (1) For modern people, alcohol is frequently consumed for relieving stress.

In 2012, the high-risk adult drinking rate dropped from 13.5% to 20.4% in 2011, but has not decreased significantly in recent 5 years, and the improvement in drinking behavior such as exercise is still insufficient. Of the annual drinkers, 42.5% of men and 13.7% of women reported drinking more than once a week. Compared to 2005 World Health Organization statistics (11.5% of drinkers worldwide drink more than once a week) (Including sex), the chances of bingeing are increasing to 2-3 times higher (2-3).

Alcohol has a relatively high calorie content of 7 kcal / g in terms of nutrition, and a decrease in the amount of food due to high caloric content results in an alcoholic malnutrition state. In addition, the intake of large quantities of alcohol or chronic alcohol may damage the gastrointestinal mucosa, leading to anorexia, discomfort in the upper abdomen, digestive disorders such as gas chills and diarrhea, as well as malnutrition and nutritional deficiencies. In addition, it exerts a toxic effect on all organs and tissues including the liver, and may develop into diseases such as hepatic necrosis, cirrhosis, pancreatitis, cardiomyopathy, neurological disorder, and cancer (4-5).

Alcohol, unlike other energy sources, is mostly degraded in the liver and alcohol that has not been degraded in the liver continues to circulate with the blood and disappears over time. Especially, Korean people have lower alcohol decomposition efficiency because they have lower activity of alcoholase than Japanese people. Therefore, there is a serious health problem due to non - metabolized alcohol. Therefore, studies are being carried out in Korea on drugs or foods that can alleviate the symptoms of alcohol detoxification and hangover. In particular, beverage hangover drinks using herbal medicine extracts are attracting attention in the domestic beverage market, (6).

It is known that the cause of hangover is closely related to blood alcohol or acetaldehyde concentration. Therefore, rapid alcohol decomposition in the body is essential for reducing hangover symptoms. The mechanism of alcohol degradation is primarily the conversion of acetaldehyde by the action of alcohol dehydrogenase (ADH), and the subsequent step is the conversion of acetic acid by acetaldehyde dehydrogenase (ALDH) acetate). At this time, when the acetaldehyde, which is an intermediate metabolite produced during alcohol decomposition metabolism, is accumulated in the body due to metabolic disturbance, it becomes a cause of toxicity due to alcohol and hangover phenomenon.

Poe-young (蒲 公英) is a dandelion ( Taraxacum an outpost of platycarpum H. Dahlstedt) or dongsok plant says the dried herbs. A flower is like a head of a goldsmith, and it is also called a gingko (잠 草 草) because it has a single stem. It is a medicine that scarcely smells and tastes and wears and turns off the fever and scalds. It is used for swelling, mastitis, sore throat, stomach (appendicitis, lung abscesses, peritonitis) and does not urinate because of eye congestion, acute hepatitis, jaundice, (7). Antimicrobial anti-inflammatory, immune function, antioxidant, anticancer and antitoxic effects are known as pharmacological agents (8-12).

However, none of the above-mentioned documents disclose any disclosure or teaching about the effects on hepatic diseases and hangovers containing an extract of Porphyra as an active ingredient.

Therefore, the inventor of the present invention has found out that the ethanol extract of Porphyrin has a dominant effect on the degradation of alcohol in blood after induction of acute alcohol while searching for natural products having the function of hangover resolution, and completed the present invention.

In order to achieve the above object, the present invention provides a pharmaceutical composition for the prevention and treatment of hangover and liver disease, which comprises an extract of Poeffean as an active ingredient.

The extracts defined herein may be extracted with water, methanol, ethanol, butanol or a solvent mixture thereof, preferably water, methanol, butanol or a mixture thereof, more preferably water and ethanol Solvent, more preferably 50 to 99% water and ethanol mixed solvent (w / w).

The liver disease as defined herein includes but is not limited to autoimmune liver disease, drug-induced liver disease, alcoholic liver disease, nonalcoholic liver disease, infectious liver disease, congenital metabolic liver disease, acute hepatitis, chronic hepatitis, liver cirrhosis, Preferably, it includes acute hepatitis, chronic hepatitis, alcoholic liver disease or nonalcoholic liver disease.

Hereinafter, the method for obtaining the extract of the present invention will be described in detail.

For example, the extract may be prepared by dissolving water, a C ₁ to C ₄ lower alcohol or a mixed solvent thereof, preferably water and an ethanol mixed solvent, in a dry state of the raw material, More preferably at room temperature or 80 ° C for 10 to 60 hours (v / w), preferably 2 to 10 times (v / w) Extraction with hot water, extraction with hot water, extraction with ultrasound, extraction with reflux or extraction with heating, preferably extraction with cold extraction, filtration and concentration under reduced pressure for about 18 to 45 hours, preferably about 18 to 45 hours, to obtain the extract of the present invention.

In addition, conventional fractionation processes may be performed (Harborne JB Phytochemical methods: A guide to modern techniques of plant analysis, 3rd ed., Pp6-7, 1998).

Accordingly, the present invention provides a pharmaceutical composition for preventing and treating hangover and liver disease, which comprises the above-described production method and the extract obtained by the method as described above as an active ingredient.

It was confirmed that the extract prepared above exhibited a therapeutic effect on hangover resolution and liver disease, which strongly suppresses the blood ethanol reduction effect and blood ALT / AST enzyme concentration in an animal experiment.

The pharmaceutical composition of the present invention comprises 0.1 to 50% by weight of the above extract, based on the total weight of the composition.

However, the composition is not limited thereto, and may vary depending on the condition of the patient, the type of disease, and the progress of the disease.

Since the extract of the present invention has little toxicity and side effects, it can be safely used even for long-term administration for the purpose of prevention.

The compositions of the present invention may further comprise suitable carriers, excipients and diluents conventionally used in the manufacture of pharmaceutical compositions.

The composition of the present invention may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories and sterilized injection solutions, Examples of carriers, excipients and diluents that can be included in the composition containing the extract include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate , Cellulose, methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose ), Lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate talc are also used. Examples of the liquid preparation for oral use include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, simple diluents commonly used, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included . Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of suppository bases include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin, and the like.

The preferred dosage of the composition of the present invention varies depending on the condition and the weight of the patient, the degree of disease, the type of drug, the route of administration and the period of time, but can be appropriately selected by those skilled in the art. However, for the desired effect, the extract of the present invention is preferably administered at 0.5 g / kg to 5 g / kg per day, preferably 1 g / kg to 3 g / kg per day. The administration may be carried out once a day or divided into several doses. Thus, the dosage amounts are not intended to limit the scope of the invention in any manner.

The composition of the present invention may be administered to mammals such as rats, mice, livestock, humans, and the like in various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine or intracerebroventricular injections.

Further, the present invention provides a health functional food for preventing and improving hangover and liver disease, which contains an extract of Poeongyong as an active ingredient.

&Quot; Health functional food "as defined herein means food prepared and processed using raw materials or ingredients having functionality useful to the human body in accordance with Law No. 6727 on Health Functional Foods." Functional " Structure and function of the nutrient to control or physiological effects, such as to obtain a beneficial effect for health is intended to eat.

The health functional food for the hangover relief and liver disease prevention of the present invention contains 0.01 to 95% by weight, preferably 1 to 80% by weight, of the above extract relative to the total weight of the composition.

In addition, it can be manufactured and processed into a health functional food in the form of tablets, capsules, powders, granules, liquids, and rings for the purpose of preventing hangover and preventing liver disease.

The present invention provides a health supplement containing the above extract of Phellinus linteus showing the effects of hangover resolution and prevention and treatment of liver disease. Examples of foods to which the extract can be added include various foods, beverages, gums, tea, vitamin complexes, and health functional foods.

The composition containing the extract of the present invention can be used variously for medicines, foods and beverages for hangover relief and prevention and improvement of liver disease. Examples of the foods to which the extract of the present invention can be added include various foods, beverages, gums, tea, vitamin complexes, health supplements and the like, and they can be used as powders, granules, tablets, capsules or beverages have.

The present invention also provides a food or food additive containing, as a main component, a Pohuto extract having a hangover resolution and prevention and improvement of liver disease. The extract of the present invention can be added to foods or beverages for the purpose of preventing hangover and preventing and improving liver disease. At this time, the amount of the extract in the food or beverage is generally from 1 to 5% by weight of the total food weight of the health food composition of the present invention, and the health beverage composition is preferably 0.02 to 10 g based on 100 ml, Can be added at a ratio of 0.3 to 1 g.

The health beverage composition of the present invention may contain various flavors or natural carbohydrates such as ordinary beverages as an additional ingredient, as long as it contains the extract as an essential ingredient at the indicated ratio, and there is no particular limitation to the liquid ingredient. Examples of the above-mentioned natural carbohydrates include monosaccharides such as disaccharides such as glucose and fructose such as maltose, sucrose and the like and polysaccharides such as dextrin, cyclodextrin and the like Sugar, and sugar alcohols such as xylitol, sorbitol, and erythritol. As natural flavors other than those described above, natural flavors (such as tau martin, stevia extract (e.g., rebaudioside A, glycyrrhizin)) and synthetic flavors (saccharin, aspartame, etc.) have. The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g per 100 mL of the composition of the present invention.

It is preferable to contain the composition for hangover decay of the present invention.

In addition, the present invention provides a hangover chew gum comprising the composition for hangover resolution according to the present invention. For example, the hangover gum may be prepared by adding to the composition for minor hangover according to the present invention the general components necessary for the production of gum, such as gum base and saccharides such as sugar, glucose, isomalt or xylitol, Can be prepared according to the usual known methods. In order to smooth the physical properties of the gum and to make the gum cohesive, saccharide syrups such as, for example, Soltitol 80, starch syrup, maltitol syrup or sorbitol syrup may be added. In addition, at least one selected from the group consisting of fragrances, stabilizers, pigments, emulsifiers and brighteners can be further added. The fragrance is added to excellence of the gum flavor, and a fragrance such as a mint flavor, a fruit flavor or a herb flavor can be used. The stabilizer may be gum arabic, gelatin, carageenan, or the like. With the addition of such stabilizers, the freshness can be maintained, the shape can be preserved, and the texture and texture of the gum can be enhanced against changes during heating or preservation during processing. In addition, the hangover chewing gum according to the present invention may be prepared by further adding natural coloring matters or synthetic coloring matters such as a flower gum, a gardenia yellow color, a caramel color or a grape skin extract pigment to enhance visual effects. Furthermore, emulsifying agents such as sucrose fatty acid esters or lecithin and polishes such as carnauba wax or shellac are further added to enhance the visual effect of the gum to uniformly disperse the flavor in the sugar solution, . The chewable gum according to the present invention preferably contains 50-500 mg, more preferably 150 mg, of the composition for a hangover remedy according to the present invention per 1.6 g of gum.

The composition for hangover decay according to the present invention may be formulated into various forms such as suspensions, pills, tablets, capsules, powders and the like, which are convenient to take in addition to the beverage and gum. Such formulations may be prepared using conventional methods known in the art

In addition to the above-mentioned composition, the composition of the present invention can be used as a flavoring agent such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, coloring agents and intermediates (cheese, chocolate etc.), pectic acid and its salts, Salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated beverages and the like. In addition, the compositions of the present invention may contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not so critical, but is generally selected in the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.

The extract of the present invention is useful in compositions for the prevention and treatment of hangover and liver disease by confirming the effect of reducing the ethanol in the blood and the therapeutic effect on the hangover and the liver disease which strongly inhibit the ALT / AST enzyme concentration in the blood Lt; / RTI >

Brief Description of the Drawings Figure 1 is a graph showing changes in blood alcohol concentration due to acute alcohol induction of the extract of the present invention;
FIG. 2 is a graph showing the effect of reducing the alcohol concentration in blood of the extract of the present invention by time,
3 is a graph showing changes in liver function by oral administration of the extract of the present invention;
Figure 4 shows the effect of liver function on liver damage induced by alcohol induction of the extract of the present invention for 8 weeks.

Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples.

However, the following Examples and Experimental Examples are merely illustrative of the present invention, and the present invention is not limited to the following Examples and Experimental Examples.

Example 1: Preparation of extract

The herbal medicine used in this experiment was purchased from Human Herb (Gyeongsan, Korea) and dried in 2012 at Cheongsong, Gyeongsang Province. Three liters of 75% EtOH aqueous solution was added to 200 g of the herb extract for 24 hours at 60 ° C . The extract was filtered through Whatman No.1 filter paper, concentrated under reduced pressure, and lyophilized for 4 days to obtain 13.58 g (6.79%, hereinafter referred to as "TPE ").

Extracted samples were dissolved in 0.9% NaCl at a suitable concentration and used as an oral drug in animal experiments. The dose was kept constant at 1 ml.

Experimental Example 1. Animal Experiment (Blood Alcohol Concentration Effect)

Experiments were carried out as described below using the method described in the existing literature in order to examine the effect of the sample obtained in the above example on the blood alcohol concentration and the enzyme concentration change in the rat.

Experimental animal

Male Sprague-Dawley rats, 200 g, were purchased from Koatech (Pyeongtaek, Korea). After visual examination of the appearance of the animals, the animals were kept in an animal room for 7 days, (N = 6) according to the method. The animals were kept at 24 ± 2 ° C and 55-60% humidity. The water and diet were fed ad libitum. To identify the animals, a card was placed in the breeding box and picric acid (Sigma-Aldrich Cat No. 319287) and weighed immediately before the experiment.

Experiment Schedule

In order to confirm the effect of reducing the alcohol concentration in the blood, the 75% ethanol extract of Porphyra was administered orally at a concentration of 1 ml per dose, and the same amount of physiological saline was administered to the normal control group and the experimental group. After one hour, the administration of alcohol was orally administered at 3 g / kg of ethanol (50%, v / v) diluted in physiological saline, and the control group was orally administered only saline.

Blood sampling and analysis of blood alcohol and biochemical components

Blood samples were collected for 45 minutes, 1 hour, 3 hours, 5 hours, 8 hours, and 24 hours after the administration of alcohol (0 hour) and alcohol. The animals were sacrificed by cervical dislocations in each group, and then harvested from the posterior vena cava, which was a blood vessel extending from the liver to the heart. The blood was immediately centrifuged at 4 ° C for 10 min at 3,000 rpm and stored at -70 ° C until analysis. Serum ethanol concentration was analyzed by the colorimetric method at 340 nm using the BioVisions ethanol assay kit (Catalog # K620-100, Milpitas, CA, USA). The enzyme (AST / ALT) (Mindray, New York, NY, USA).

As a result of the above experiment, the alcohol concentration of the extract of the present invention (100 mg / kg) increased by 10 times from 45 minutes to 8 hours after alcohol induction. (200 mg / kg) reduced by up to 29% (see Tables 1 and 2 and Figures 1 - 2)

Time (h) Blood alcohol concentration (nmol / μl, mean ± sem) 0 01 ± 0.31 0.75 10.4 ± 0.83 3 11.0 + - 0.14 5 10.8 ± 0.39 8 10.1 ± 0.53 24 2.2 ± 0.21

 Experimental group Concentration (mg / ml) Time (h) Blood alcohol concentration (nmol / μl, mean ± sem) NC - 0 0.1 ± 0.31 PC - 0.75 10.4 ± 0.83 3 11.0 + - 0.14 8 10.1 ± 0.53 TPE 100 0.75 11.2 ± 0.22 3 10.9 ± 0.09 8 3.6 ± 0.26 200 0.75 10.9 ± 0.10 3 10.8 ± 0.14 8 3.0 ± 0.04 Ref. 200 0.75 11.5 ± 0.12 3 10.9 ± 0.39 8 11.3 ± 0.12

(AST / ALT), which is an indicator of liver function (see Table 3 and FIG. 3).

Single oral doses up to 200 mg / kg of extract did not significantly affect changes in liver function (AST / ALT enzyme levels) in rats.

 Experimental group Concentration (mg / ml) Time (h) Serum AST
(IU, mean 占 sem sem) Serum ALT
(IU, mean 占 sem sem) NC - 0 94 ± 1.63 62 ± 4.90 PC - 0.75 109 ± 4.90 68 ± 2.04 3 109 ± 12.26 70 ± 2.04 5 123 ± 19.21 57 ± 1.63 8 123 ± 5.31 59 ± 2.86 24 97 ± 2.86 59 ± 2.04 TPE 100 0.75 135 ± 8.12 79 ± 0.67 3 121 ± 4.90 71 ± 1.23 8 106 ± 0.88 52 ± 2.97 200 0.75 123 ± 16.76 71 ± 5.31 3 112 ± 14.71 65 ± 2.04 8 118 ± 4.09 92 ± 24.93 Ref. 200 0.75 124 ± 2.97 58 ± 4.36 3 71 ± 21.95 22 ± 18.72 8 103 ± 11.85 55 ± 6.39

Experimental Example 2. Animal Experiment (Hepatocyte Protection Effect)

In order to confirm the effect of the protective action on the hepatic injury by alcohol induction in the rats of the above-mentioned examples, the following experiment was carried out using the method described in the existing literature (13, 14).

2.1. Experiment Schedule

In order to confirm the protective effect of liver injury by alcohol induced induction, 75% ethanol extract of Porphyry were orally administered at a concentration of 1 ml per day for 8 weeks, Of physiological saline were administered for the same period. Alcohol was administered orally for 3 g / kg of ethanol (30%, v / v) diluted in physiological saline every day. Oral administration of saline alone was administered to the control group.

2.2. Blood sampling and analysis of blood alcohol and biochemical components

Experimental animal sacrifices for acute alcohol induction and alcohol induction for 8 weeks were obtained from the cervical dislocations in each group and then in the posterior vena cava, which is a vein from the liver to the heart. The blood was immediately centrifuged at 4 ° C for 10 min at 3,000 rpm and stored at -70 ° C until analysis. Blood samples were collected for 45 minutes, 1 hour, 3 hours, 5 hours, 8 hours, and 24 hours after the administration of alcohol (0 hour) and alcohol. Serum ethanol concentration was analyzed at 340 nm by colorimetric method using BioVision's ethanol assay kit (Catalog # K620-100, Milpitas, CA, USA). The enzyme (AST / ALT) (Mindray, New York, NY, USA).

2.3. Organ harvesting and hematoxylin & eosin (H & E) tissue staining

Liver tissue was removed, peripheral fat and water were removed, weighed, and fixed at 10% formalin to evaluate the inhibitory effect of alcohol induced liver inflammation. Fixed liver tissues were washed with water and dehydrated, cleaned, paraffin - infiltrated with an automatic tissue processor and embedded in paraffin - embedded tissue sections. After attaching it to the slides, paraffin was removed using xylene and ethanol, nuclear staining was performed with hematoxylin through a functional process, followed by washing with distilled water and staining cytoplasm using eosin. The slide was then mounted and observed using an optical microscope.

2.4 Experimental Results

As a result of the above experiment, serum AST, ALT and ALP activities indicating the liver function and damage level of the experimental animals were increased compared to the normal group after 8 weeks of alcohol induction. In the same period, administration of the extract of the present invention (100 mg / kg) , The AST activity was 30%, the ALT activity was 25%, and the ALP activity was 4% by the administration of the extract (200 mg / kg), while the AST activity was decreased by 25% (AST), ALT activity (ALT) and ALP activity (ALP) were reduced by 31%, 28%, and 31%, respectively. Increases in inflammatory cells of liver tissue were also significantly reduced in all concentration groups. (See Table 4 and Fig. 4).

Hepatic protection efficacy of ethanol extract of porcine feces in rat liver injury induced by alcohol induction for 8 weeks  Experimental group Concentration (mg / kg) AST
(IU / L, mean 占 sem sem) ALT
(IU / L, mean 占 sem sem) ALP
(IU / L, mean 占 sem sem) T-Protein (g / dl, mean 占 sem sem) Albumin (g / dl, mean 占 sem sem) NC - 149 ± 13.1 54 ± 0.4 421 ± 12.2 7.4 ± 0.07 4.3 ± 0.03 PC - 191 ± 2.9 72 ± 4.1 499 ± 9.7 7.1 ± 0.18 4.0 ± 0.12 TPE 100 164 ± 11.7 61 ± 5.1 393 ± 50.1 7.4 ± 0.09 4.3 ± 0.16 200 135 ± 13.5 55 ± 3.2 480 ± 9.5 7.9 ± 0.06 4.4 ± 0.09 400 140 ± 5.8 60 ± 1.4 346 8.3 7.5 ± 0.06 4.3 ± 0.09 Ref. 100 119 ± 2.8 58 ± 0.4 400 ± 9.8 7.4 ± 0.20 4.3 ± 0.10 200 148 ± 16.2 47 ± 2.8 397 ± 28.3 7.5 ± 0.15 4.1 ± 0.08 400 170 ± 14.3 49 ± 2.6 334 ± 4.7 7.6 ± 0.23 4.4 ± 0.07

Hereinafter, formulation examples of the composition containing the extract of the present invention will be described, but the present invention is not intended to be limited thereto but is specifically explained.

Preparation Example 1. Preparation of powder

TPE Extract ------------------------------------------ 20 mg

Lactose ------------------------------------------------ 100 mg

Talc ------------------------------------------------- 10 mg

The above components are mixed and filled in airtight bags to prepare powders.

Formulation Example 2. Preparation of tablets

TPE extract --------------------------------------------- 10 mg

Corn starch -------------------------------------------- 100 mg

Lactose ------------------------------------------------- - 100 mg

Magnesium stearate ------------------------------------- 2 mg

After mixing the above components, tablets are prepared by tableting according to the usual preparation method of tablets.

Formulation example  3. Preparation of capsules

TPE Extract ------------------------------------------- 10 mg

Crystalline cellulose ---------------------------------------- 3 mg

Lactose ---------------------------------------------- 14.8 mg

Magnesium stearate 0.2 mg < RTI ID = 0.0 >

The above components are mixed according to a conventional capsule preparation method and filled in gelatin capsules to prepare capsules.

Formulation Example 4. Preparation of injection

TPE Extract ------------------------------------------- 10 mg

Mannitol ------------------------------------------------- 180 mg

Sterile sterile distilled water for injection ------------------------------------ 2974 mg

Na ₂ HPO _4, 12H ₂ O ------------------------------------------ - 26 mg

(2 ml) per 1 ampoule according to the usual injection preparation method.

Formulation Example 5. Preparation of a liquid preparation

TPE Extract ------------------------------------------- 20 mg

Isseong Party ------------------------------------------------ - 10 g

Mannitol ------------------------------------------------- --- 5 g

Purified water ------------------------------------------------- - Suitable amount

Each component was added to purified water in accordance with the usual liquid preparation method and dissolved, and the lemon flavor was added in an appropriate amount. Then, the above components were mixed, and purified water was added thereto. The whole was adjusted to 100 ml with purified water, And sterilized to prepare a liquid preparation.

Claims (8)

A pharmaceutical composition for the prevention and treatment of hangover and liver disease, which comprises an extract of Porphyra as an active ingredient. The pharmaceutical composition according to claim 1, wherein the extract is soluble in a solvent selected from water, methanol, ethanol, butanol or a mixed solvent thereof. The method of claim 1, wherein the liver disease is selected from the group consisting of autoimmune liver disease, drug-induced liver disease, alcoholic liver disease, nonalcoholic liver disease, infectious liver disease, congenital metabolic liver disease, acute hepatitis, chronic hepatitis, liver cirrhosis, Or liver cancer. A health functional food for the prevention and improvement of hangover and liver disease containing the extract of porkyong as an active ingredient. The health functional food according to claim 4, wherein the health functional food is a tablet, a capsule, a powder, a granule, a liquid, or a ring. Which is effective in the prevention and treatment of hangover and liver disease. The health supplement according to claim 6, wherein the health supplement is in the form of powder, granule, tablet, capsule, beverage, gum, tea, vitamin complex. A food or food additive containing as a main ingredient an extract of Poeongyong showing the effect of preventing hangover and preventing and improving liver disease.

Images